Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma

Cellular Physiology and Biochemistry

Volumn 36, Issue 3, 2015, Pages 1175-1185

  Cai, Ming ^a   Wang, Zhiqiang ^a   Zhang, Jiru ^a   Zhou, Huan ^a   Jin, Linfang ^a   Bai, Ruizhen ^a   Weng, Yuan ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

ADAM17; EMT; Invasion; Lung adenocarcinoma; miR 326

Indexed keywords

MICRORNA; MICRORNA 326; NERVE CELL ADHESION MOLECULE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ADAM PROTEIN; ANTISENSE OLIGONUCLEOTIDE; LUCIFERASE; MIRN326 MICRORNA, HUMAN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ADULT; ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; AGED; ANTAGONISTS AND INHIBITORS; CARCINOGENESIS; CELL MOTION; DIFFUSION CHAMBER; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAM PROTEINS; ADENOCARCINOMA; AGED; BASE SEQUENCE; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; DIFFUSION CHAMBERS, CULTURE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; SIGNAL TRANSDUCTION;

EID: 84933563935     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430288     Document Type: Article

References (26)

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Aydin D, Bilici A, Yavuzer D, Kefeli U, Tan A, Ercelep O, Mert A, Yuksel S, Ozcelik M, Isik D, Surmeli H, Odabasi H, Aliustaoglu M: Prognostic significance of adam17 expression in patients with gastric cancer who underwent curative gastrectomy. Clin Transl Oncol 2015, epub ahead of print.
3. Liu Y, Wu C, Wang Y, Wen S, Wang J, Chen Z, He Q, Feng D: Microrna-145 inhibits cell proliferation by directly targeting adam17 in hepatocellular carcinoma. Oncol Rep 2014;32:1923-1930.
4. Lv X, Li Y, Qian M, Ma C, Jing H, Wen Z, Qian D: Adam17 silencing suppresses the migration and invasion of non-small cell lung cancer. Mol Med Rep 2014;9:1935-1940.
5. Ni SS, Zhang J, Zhao WL, Dong XC, Wang JL: Adam17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival. Tumour Biol 2013;34:1813-1818.
6. Cheng L, Yang T, Kuang Y, Kong B, Yu S, Shu H, Zhou H, Gu J: Microrna-23a promotes neuroblastoma cell metastasis by targeting cdh1. Oncol Lett 2014;7:839-845.
7. Rostas JW, 3rd, Pruitt HC, Metge BJ, Mitra A, Bailey SK, Bae S, Singh KP, Devine DJ, Dyess DL, Richards WO, Tucker JA, Shevde LA, Samant RS: Microrna-29 negatively regulates emt regulator n-myc interactor in breast cancer. Mol Cancer 2014;13:200.
8. Feng X, Wang Y, Ma Z, Yang R, Liang S, Zhang M, Song S, Li S, Liu G, Fan D, Gao S: Microrna-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor ifit2. BMC cancer 2014;14:633.
9. Wu N, Zhang C, Bai C, Han YP, Li Q: Mir-4782-3p inhibited non-small cell lung cancer growth via usp14. Cell Physiol Biochem 2014;33:457-467.
10. Wu L, Hui H, Wang LJ, Wang H, Liu QF, Han SX: Microrna-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein. Oncol Rep 2015;33:2309-2318.
11. Valencia K, Martin-Fernandez M, Zandueta C, Ormazabal C, Martinez-Canarias S, Bandres E, de la Piedra C, Lecanda F: Mir-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis. Bone 2013;52:532-539.
12. Wang R, Chen XF, Shu YQ: Prediction of non-small cell lung cancer metastasis-associated micrornas using bioinformatics. Am J Cancer Res 2015;5:32-51.
13. Li G, Forest F, Feng G, Gentil-Perret A, Peoc'h M, Cottier M, Mottet N: A novel marker adam17 for clear cell renal cell carcinomas: Implication for patients' prognosis. Urol Oncol 2014;32:1272-1276.
14. Beck Gooz M, Maldonado EN, Dang Y, Amria MY, Higashiyama S, Abboud HE, Lemasters JJ, Bell PD: Adam17 promotes proliferation of collecting duct kidney epithelial cells through erk activation and increased glycolysis in polycystic kidney disease. Am J Physiol Renal Physiol 2014;307:F551-559.
15. Baumgart A, Seidl S, Vlachou P, Michel L, Mitova N, Schatz N, Specht K, Koch I, Schuster T, Grundler R, Kremer M, Fend F, Siveke JT, Peschel C, Duyster J, Dechow T: Adam17 regulates epidermal growth factor receptor expression through the activation of notch1 in non-small cell lung cancer Cancer Res 2010;70:5368-5378.
16. Dong H, Xie L, Tang C, Chen S, Liu Q, Zhang Q, Zheng W, Zheng Z, Zhang H: Snail1 correlates with patient outcomes in e-cadherin-preserved gastroesophageal junction adenocarcinoma. Clin translat Oncol 2014;16:783-791.
17. Liu Y, Li H, Feng J, Cui X, Huang W, Li Y, Su F, Liu Q Zhu J, Lv X, Chen J, Huang D, Yu F: Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells. PloS one 2013;8:e83083.
18. Bao YX, Cao Q Yang Y, Mao R, Xiao L, Zhang H, Zhao HR, Wen H: Expression and prognostic significance of golgiglycoprotein73 (gp73) with epithelial-mesenchymal transition (emt) related molecules in hepatocellular carcinoma (hcc). Diagn Pathol 2013;8:197.
19. Krol J, Loedige I, Filipowicz W: The widespread regulation of microrna biogenesis, function and decay. Nat Rev Gen 2010;11:597-610.
20. Calin GA, Croce CM: Microrna signatures in human cancers. Nat Rev Cancer 2006;6:857-866.
21. Iwagami Y, Eguchi H, Nagano H, Akita H, Hama N, Wada H, Kawamoto K, Kobayashi S, Tomokuni A, Tomimaru Y, Mori M, Doki Y: Mir-320c regulates gemcitabine-resistance in pancreatic cancer via smarcc1. Br J Cancer 2013;109:502-511.
22. Kang IH, Jeong BC, Hur SW, Choi H, Choi SH, Ryu JH, Hwang YC, Koh JT: Microrna-302a stimulates osteoblastic differentiation by repressing coup-tfii expression. J Cell Physiol 2015;230:911-921.
23. Price NL, Ramirez CM, Fernandez-Hernando C: Relevance of microrna in metabolic diseases. Crit Rev Clin Lab Sci 2014:1-16. 2014 Dec;51(6):305-20.
24. Xia Y, Chen Q, Zhong Z, Xu C, Wu C, Liu B, Chen Y: Down-regulation of mir-30c promotes the invasion of non-small cell lung cancer by targeting mta1. Cell Physiol Biochem 2013;32:476-485.
25. Zhang H, Zhao M, Lv Z, Zhang X, Qin X, Wang H, Wang S, Su J, Lv X, Liu H, Du W, Zhou W, Chen X, Fei K: Mir-138 inhibits tumor growth through repression of ezh2 in non-small cell lung cancer. Cell Physiol Biochem 2013;31:56-65.
26. Du B, Wang Z, Zhang X, Feng S, Wang G, He J, Zhang B: Microrna-545 suppresses cell proliferation by targeting cyclin d1 and cdk4 in lung cancer cells. PLoS One 2014;9:e88022.